Yes mechanistically, peptides like BPC-157 and thymosin beta-4 target tissue repair pathways (VEGF, epithelial migration) that are independent of acid suppression, so combining them with PPIs addresses both damage prevention (acid control) and mucosal healing
Whichever you choose, read the current certificate of analysis before you buy, and keep everything strictly for laboratory research use, which is the only basis the FDAs drug-approval process leaves open
It remains an experimental compound without formal clinical guidelines for dosage or usage
At Your Skin Prescription, our skilled aestheticians prioritize your comfort, walking you through every step so you know exactly what to expect in our relaxing and stress-free environment
Subcutaneous injections can be less painful and easier to do yourself
The Bottom Line Although AOD-9604, MOTS-c, Tesamorelin, Semaglutide, and Tirzepatide are often discussed together, they serve very different purposes